FAM
ANIK icon

Fred Alger Management’s Anika Therapeutics ANIK Stock Holding History

Fred Alger Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-138,851
Closed -$6.21M – 527
2016
Q1 		$6.21M Buy
+138,851
New +$5.63M 0.03% 230

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Fred Alger Management's ANIK Position: Q2 2016 in Review

Fred Alger Management sold out of Anika Therapeutics (ANIK) in Q2 2016, closing a stake of 138,851 shares — an estimated $6.21M sold.

Fred Alger Management first reported a position in ANIK in Q1 2016 and held it in 1 quarter. The position peaked at $6.21M in Q1 2016. 160 funds tracked by Wall St. Rank hold ANIK as of Q2 2016.

  • Fred Alger Management reported no remaining Anika Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Fred Alger Management sold 138,851 Anika Therapeutics shares in Q2 2016, an estimated $6.21M.
  • Fred Alger Management first reported a position in Anika Therapeutics in Q1 2016 and held it in 1 quarter.
  • Fred Alger Management's Anika Therapeutics position peaked at $6.21M in Q1 2016.
  • 160 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2016.

Based on Fred Alger Management's 13F filing for Q2 2016, filed 15 Aug 2016.